DTIL
Price:
$7.26
Market Cap:
$55.69M
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the ris...[Read more]
Industry
Biotechnology
IPO Date
2019-03-28
Stock Exchange
NASDAQ
Ticker
DTIL
According to Precision BioSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -12753119.00. This represents a change of -47.64% compared to the average of -24358795.30 of the last 4 quarters.
The mean historical Enterprise Value of Precision BioSciences, Inc. over the last ten years is 109.73B. The current -12753119.00 Enterprise Value has changed -101.16% with respect to the historical average. Over the past ten years (40 quarters), DTIL's Enterprise Value was at its highest in in the March 2019 quarter at 775.57M. The Enterprise Value was at its lowest in in the September 2023 quarter at -81462413.66.
Average
109.73B
Median
378.58M
Minimum
-57942498.60
Maximum
875.64B
Discovering the peaks and valleys of Precision BioSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.46%
Maximum Annual Enterprise Value = 875.64B
Minimum Annual Increase = -119.33%
Minimum Annual Enterprise Value = -57942498.60
Year | Enterprise Value | Change |
---|---|---|
2023 | -43346199.15 | -25.19% |
2022 | -57942498.60 | -119.33% |
2021 | 299.74M | -15.49% |
2020 | 354.67M | -11.88% |
2019 | 402.49M | -46.47% |
2018 | 751.89M | 43.46% |
2017 | 524.12M | -99.94% |
The current Enterprise Value of Precision BioSciences, Inc. (DTIL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
66.15M
5-year avg
191.12M
10-year avg
109.73B
Precision BioSciences, Inc.’s Enterprise Value is less than X4 Pharmaceuticals, Inc. (38.44M), less than Acumen Pharmaceuticals, Inc. (139.19M), less than Inozyme Pharma, Inc. (202.73M), less than Terns Pharmaceuticals, Inc. (222.97M), less than Day One Biopharmaceuticals, Inc. (963.46M), less than Eledon Pharmaceuticals, Inc. (233.30M), greater than HOOKIPA Pharma Inc. (-36166707.00), less than Mereo BioPharma Group plc (496.22M), less than Galera Therapeutics, Inc. (-7482657.00), less than Passage Bio, Inc. (24.72M), less than Black Diamond Therapeutics, Inc. (139.97M), less than TCR2 Therapeutics Inc. (79.12M), less than Harpoon Therapeutics, Inc. (861.85M), less than Alector, Inc. (383.33M), less than Stoke Therapeutics, Inc. (457.69M), less than Pliant Therapeutics, Inc. (770.48M), less than Dyne Therapeutics, Inc. (2.51B), less than Cytokinetics, Incorporated (6.54B), less than Revolution Medicines, Inc. (9.43B),
Company | Enterprise Value | Market cap |
---|---|---|
38.44M | $57.64M | |
139.19M | $142.39M | |
202.73M | $180.51M | |
222.97M | $491.80M | |
963.46M | $1.38B | |
233.30M | $239.55M | |
-36166707.00 | $20.76M | |
496.22M | $575.61M | |
-7482657.00 | $2.07M | |
24.72M | $31.19M | |
139.97M | $143.73M | |
79.12M | $58.11M | |
861.85M | $865.08M | |
383.33M | $385.85M | |
457.69M | $605.41M | |
770.48M | $789.88M | |
2.51B | $3.02B | |
6.54B | $5.79B | |
9.43B | $9.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precision BioSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Precision BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Precision BioSciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Precision BioSciences, Inc. (DTIL)?
What is the 3-year average Enterprise Value for Precision BioSciences, Inc. (DTIL)?
What is the 5-year average Enterprise Value for Precision BioSciences, Inc. (DTIL)?
How does the current Enterprise Value for Precision BioSciences, Inc. (DTIL) compare to its historical average?